AI Bias Analysis
4 models · Takes ~15 seconds
At the start of last year, Micron wasn’t even among the top 100 U.S. companies. Its fortunes have changed dramatically since then.
Source
MarketWatch
Opens original article in a new tab
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.
Man Group CEO Robyn Grew discusses the market impacts of the Iran War in both the US and Europe, and why we are beginning to see a shift toward diverse and resilient portfolios. She speaks with Katie Greifeld and Romaine Bostick at the Milken Institute Global Conference in Beverly Hills, California. (Source: Bloomberg)
A new study tries to put a number on the value of reliable numbers
GlobalFoundries just introduced a new technology to boost the use of co-packaged optics in AI data centers.
